Methadone (0.2 mg/kg IV q6h) and metamizole (25 mg/kg IV q8h) were used for analgesia, avoiding the use of non-steroidal anti-inflammatory drugs (NSAIDs) owing to safety concerns and unknown patient status at admission. Blood test abnormalities indicated neutrophilia (16, . When reassessing pain, mechanical allodynia was evidenced by an extreme reaction when the skin was lightly rubbed and stroked with fingers or a gauze, and thermal hyperalgesia was revealed as marked sensitivity when placing an icepack (Figure 1 ).
The patient was sedated so that we could perform an abdominal ultrasound. A transversus abdominis plane (TAP) block with bupivacaine (1 mg/kg) was incomplete owing to the difficulty in seeing the muscle layers. The ultrasound revealed a loss of continuity of the abdominal muscular wall at the right inguinal area, which likely left the block incomplete. Passage of the jejunum and the presence of a mass of 2.8 × 2.3 cm was located in the mid-abdomen, suggesting focal adherences, hematoma or abscess. Exploratory laparotomy was scheduled.
The procedure was performed 24 h after admission and lasted 2 h. Surgery corrected the hernia, resecting 1 × 2 cm of muscular wall and releasing the intestine (duodenum and jejunum) that was attached to the abdominal wall. The anesthetic protocol consisted of methadone (0.2 mg/kg IV), ketamine (2.5 mg/kg IV)/ midazolam (0.25 mg/kg IV), maintenance with isoflurane and an epidural injection (bupivacaine 0.5%: 0.3 ml/kg; morphine: 0.1 mg/kg). Upon skin and muscle incision, the patient showed a sympathetic response (tachycardia, hypertension and tachypnea). Fentanyl (5 µg/kg/h) and ketamine (0.6 mg/kg/h) constant rate infusion (CRI) was initiated; tachycardia (204 bpm) and tachypnea (40 breaths per minute) persisted, but blood pressure dropped. Postoperatively, dexamethasone was administered (0.5 mg/kg IV). A manually created wound-diffusion catheter was created from a 21 G butterfly catheter, sealed with a heat source and fenestrations were made from a through-and-through puncture with a 21 G hypodermic needle. The wound-diffusion catheter was placed subcutaneously at the closure site for bupivacaine administration.
During anesthesia recovery, the patient was able to walk but appeared hyperreactive to auditory stimuli and ataxic, and the fentanyl and ketamine infusions were suspended 45 mins postoperatively. The patient continued with abdominal pain (UNESP-Botucatu MCPS score 15/30), mechanical allodynia, thermal hyperalgesia and a facial expression characterized by narrowed eyes (Figure 2 ). Therefore, rescue analgesia was initiated with methadone (0.2 mg/kg IV q4h), and the first dose of bupivacaine was placed through the subcutaneous (SC) wound-diffusion catheter (1 mg/kg q8h).
Despite analgesic rescue, 1 h later the pain score remained high (15/30) . The patient was re-sedated, a TAP block (bupivacaine 1 mg/kg) was repeated and coadjuvant therapy was initiated with pregabalin (3 mg/ kg PO q12h). A session of electroacupuncture (EA) was held for 20 mins at mixed frequencies (high and low) at points ST36 (master point of the gastrointestinal tract and abdomen) + SP6 (master point of the caudal abdomen and urogenital system); EA appeared to be well tolerated. Pain score decreased to 12/30 1 h after EA (Figure 3 ) but remained higher than the score described for rescue analgesia (>7/30). 1 Meloxicam was initiated at 0.2 mg/kg SC (continuing at 0.1 mg/kg SC q24h). Two hours later, the pain score had decreased to 8/30. Twenty-four hours postoperatively, the patient accepted food, showed less response to abdominal palpation and the pain score decreased to 6/30 ( Figure 4) . Methadone (0.2 mg/kg IV q4h), metamizole (25 mg/kg IV q8h), pregabalin (3 mg/kg PO q12h), meloxicam (0.1 mg/kg q24h) and bupivacaine (1 mg/kg SC wound-diffusion catheter q8h) were continued.
Forty-eight hours postoperatively, the wound catheter was removed, and the pain score increased to 12/30 ( Figure 5 ). Ketamine CRI (0.6 mg/kg/h) was initiated, and the methadone dosage and frequency were increased to 0.3 mg/kg intravenously every 4 h.
Forty-eight hours after initiating the ketamine CRI and increasing the dose and frequency of methadone, the patient no longer demonstrated allodynia and the pain score was 8/30 ( Figure 6 ). An EA session was repeated. Twenty-four hours later (72 h after initiating the ketamine CRI and increased dose and frequency of methadone, 120 h postoperatively), the ketamine and methadone dosages were reduced to 0.3 mg/kg/h and 0.2 mg/kg IV q6h, respectively. Six days after surgery, the ketamine infusion was suspended.
Ten days after surgery, the pain score was 5/30 and methadone was discontinued. Tramadol (3 mg/kg IV q8h) was initiated until discharge.
Ketamine was continued for 6 days; metamizole for 7 days; methadone for 12 days; and meloxicam for 14 days. Fourteen days post-admission, the patient was discharged with tramadol (3 mg/kg PO q8h for 7 days; oral drops were mixed with food due to the bitter taste) and pregabalin (3 mg/kg PO q12h for 60 days) ( Figure 7 ).
Discussion
This report presents a case of severe pain, suggesting a type of 'mixed pain', where nociceptive (inflammatory) and neuropathic pain coexist, 2 requiring the use of different strategies for relief. Nociceptive pain is normally processed by the somatosensorial system, whereas neuropathic pain is generated by damage or dysfunction in the somatosensorial system. 3 Development of neuropathic pain involves central and peripheral sensitization, characterized by ectopic activity of afferent fibers, decreased inhibitory modulation, pathological activation of microglia and phenotypic change in mechanoreceptive A-beta fibers. 2,4 Possible contributors to the neuropathic component of this patient's pain included injury of peripheral nerves (eg, iliohypogastric nerve), major trauma, poor analgesia, surgical procedures and stress (considering that stress exacerbates neuropathic pain via glucocorticoid receptors and microglial activation). 5 The characteristics and refractoriness to treatment with opioids and NSAIDs suggested persistent postoperative pain (PPP) with a neuropathic component. 4,6 PPP in humans is defined as clinical discomfort that lasts more than 2 months postoperatively, but remains uncharacterized in animals. Neuropathic pain has been described in dogs after correction of perineal hernia, 7 in humans after inguinal herniorrhaphy and in cats post-amputation. 8, 9 Neuropathic pain is manifested by allodynia, hyperalgesia, hyperesthesia, dysesthesias, expanded field and intermittent spontaneous pain and is frequently unresponsive to conventional analgesic drugs. 10 Table 1 shows some simple tests that can be performed to identify allodynia and hyperalgesia in humans. Mathews has suggested an adaptation of these tools to assess allodynia and hyperalgesia in animals. 4 The UNESP-Botucatu MCPS (a trustworthy and sensitive tool for cats and validated in Spanish) was used for postoperative pain assessment. 1 It integrates the observation of patient behavior without and then with interaction features included in the most reliable clinical pain measurement instruments. 11 Initially, the patient received methadone and metamizole, eliciting a mild response. Metamizole is a non-opioid analgesic drug, sometimes incorrectly classified as an NSAID. The mechanism responsible for the analgesic effect is probably the inhibition of a central cyclooxygenase (COX) 3 and activation of the opioidergic system and cannabinoid system. 12 Its pharmacokinetics profile has been described in cats. 13 Methadone is an opioid agonist and a weak NMDA receptor antagonist. 14 Opioid receptors, found in the brain, spinal cord and peripheral tissues, reduce the release of excitatory neurotransmitters and cause hyperpolarization of neurons. 15, 16 In cats, methadone provides effective analgesia for procedures such as orchiectomy and ovariohysterectomy. 17, 18 The patient was subsequently placed on fentanyl CRI; in cats, fentanyl has elicited an increase in thermal and mechanical nociceptive thresholds. 19 Ideally, opioids should be used before a painful stimulus, thus preventing sensitization of the central nervous system; 14 however, in this case, they were administered 7 days post-trauma. Complications of opioid therapy include vomiting, inappetence, reduced intestinal motility, urinary retention, opioid-induced hyperalgesia and tolerance (reported in humans). 14, 20 Nevertheless, none of these effects were observed.
For the abdominal herniorrhaphy, an epidural regional block was performed; however, the blockade appeared to fail and rescue analgesia was necessary. Failure rates of epidurals are 23% in humans, 7% in dogs and 9% in cats. 21, 22 The ketamine and fentanyl CRIs were suspended after surgery when hyperreactivity and ataxia were observed. Both behaviors have been described as adverse effects of opioids 23 and ketamine during anesthesia recovery. 16, 24 As alternatives, the rate of either or both drug infusions could have been decreased, or only one infusion discontinued. Ketamine is a phencyclidine dissociative anesthetic at higher doses. When administered subanesthetically by CRI, it still shows activity in the spinal cord dorsal horn, blocking the NMDA receptor and reducing wind-up and central sensitization. 25, 26 Subanesthetic doses are described in humans and dogs. 25, 27 In cats not experiencing pain, with a lack of central sensitization, subanesthetic ketamine CRI minimally affects thermal and mechanical antinociception. 28 In this patient, with central sensitization presumed present, the treatment appeared to generate a positive response.
A TAP block was performed twice in this patient. TAP block is an alternative to neuraxial techniques and blocks the neural afferent of the abdominal wall through the introduction of local anesthetic in the interfascial plane between the transversus abdominis and internal oblique muscles. [29] [30] [31] The first blockade was deemed only partially effective, owing to the loss of muscle generated by the trauma. Analgesia was complemented with EA. The proposed mechanism of analgesic action for EA involves activation of chemically bioactive substances (including opioids, serotonin and norepinephrine) through peripheral, spinal and adrenal mechanisms; desensitization of peripheral nociceptors; and reduction of the release of proinflammatory cytokines at a peripheral level and in the spinal cord. EA at low and high frequencies inhibits pain through the mu, delta and kappa opioid receptors. 32, 33 EA at acupoints ST36 and SP6 reduced postoperative analgesic requirements in cats undergoing ovariohysterectomy. 34 Although pain scores decreased with these interventions, scores remained above the limit for rescue analgesia (>7/30). Meloxicam was added 12 h postoperatively, which may have been too close in time to the administration of dexamethasone, considering its prolonged biological activity. 35, 36 Dexamethasone might be a useful adjunct to a multimodal analgesia, due to anti-inflammatory effects, as well as interactions with opioid receptors, 37 eliciting benefits such as a reduction in pain and in opioid consumption in humans; 38 however, the benefits must be weighed against the adverse effects, especially gastrointestinal damage when given in close proximity to NSAIDs.
The pain score decreased after meloxicam administration, presumably through its peripheral and central antiinflammatory and analgesic effects. NSAIDs act by inhibiting the production of prostaglandins generated by the COX-1 and COX-2 enzymes. Meloxicam is metabolized in the liver by oxidative pathways, in contradistinction to other NSAIDs that require glucuronidation, in which cats are deficient. 39 In this case, meloxicam was administered for a longer period than recommended by the manufacturer (single dose) owing to ongoing inflammation and pain. Adverse effects associated with NSAID administration, such as acute kidney injury, gastrointestinal ulcers and gastroenteritis, 35 were not observed. The safety of long-term low-dosage meloxicam has been described for chronic pain treatment in clinically stable cats. [40] [41] [42] Wound-diffusion catheters are described as tools for postoperative pain management in humans, dogs, cats and goats. 43, 44 The catheter was in place for 2 days, based on a previous study in cats. 44 The pain score increased after removal, presumably due to the loss of local anesthetic blocking somatic sensation.
Gabapentinoids are used for treatment and prevention of maladaptive pain and have been approved by the Food and Drug Administration for use in humans in diabetic neuropathy, post-herpetic neuralgia and fibromyalgia. 45 They enhanced the effect of other analgesics in patients with hyperalgesia and allodynia. 46, 47 Gabapentin has been described as an analgesic in multiple surgical settings in dogs and cats, with variable outcomes. [48] [49] [50] [51] [52] Pregabalin was chosen over gabapentin because it is less expensive in this country. Pregabalin is a structural analog of gamma-aminobutyric acid (GABA). Its mechanism of action is not related to GABA and is not completely elucidated; however, the compound binds to the alpha2-delta voltage-gated calcium channel subunit, inhibiting calcium influx at the spinal and supraspinal levels and decreasing the release of neurotransmitters, including glutamate and substance P. 53 Pregabalin is used as an anticonvulsant and analgesic in humans, but little information exists for animals, with only one published pharmacokinetic report for cats. 53, 54 The analgesic response to pregabalin was uncertain in this patient as subanesthetic ketamine CRI was initiated at the same time, and pharmacokinetics in cats indicate that the steady-state concentration is not reached for 2 days. 54 Tramadol acts in opioidergic, serotoninergic and adrenergic pathways in cats and has elicited thermal antinociception and shown efficacy for treating acute pain in this species. [55] [56] [57] The mu-agonist active metabolite O-desmethyl-tramadol remains high for longer in cats, in comparison with dogs, with a half-life of 261 ± 28 mins (IV administration) and contributes to analgesia. 58 It was difficult to know which treatments most contributed to pain relief, but adding meloxicam to the therapy did significantly lower pain scores. Three different locoregional anesthetic techniques (epidural, TAP block, wound-diffusion catheter) were used. Two were not completely successful, likely because of anatomical difficulties (TAP block) or failure of the technique (epidural). However, bupivacaine every 8 h through the wound-diffusion catheter appeared effective, as patient pain scores increased when the catheter was removed.
Conclusions
Multimodal pharmacologic and non-pharmacologic interventions were used to reduce pain and allodynia, and complementary analgesic therapies, such as EA and anticonvulsants, were needed to reduce pain, allodynia and hyperalgesia in a cat with neuropathic pain after major trauma and post-herniorrhaphy. A validated clinical pain-scoring instrument (UNESP-Botucatu MCPS) was successfully used to monitor patient status and guide the patient's analgesic therapy.
